Novo Nordisk
Coverage falls mostly under Business (5) , Economy (2) and Health (2) .
All coverage
9 stories-
Business
Novo Nordisk strikes second licensing deal since frosty capital-markets day
MarketWatch -
Health
Novo Nordisk's next-gen weight loss drug outperforms Zepbound in new trial
The Hill -
Business
Pharma stock soars 150% on injectables deal with Wegovy maker Novo
CNBC Top News -
Business
After capital-markets day flop, Novo strikes licensing deal that sends a Swedish company’s stock soaring
MarketWatch -
Economy
U.S. demand for Novo Nordisk’s weight loss drugs is so huge that the Danish central bank just doubled the nation’s entire growth forecast
Fortune -
Business
Novo Nordisk stock falls after 2030 strategy disappoints investors
Yahoo Finance -
Business
Novo Nordisk stock gets drilled on pipeline concerns -- its CEO sees this as the main problem
Yahoo Finance -
Economy
Novo Nordisk stock tumbles as Ozempic maker sets out 2030 goals
MarketWatch -
Health
Moderna’s Bob Langer and AI pioneer Yann LeCun join board of Cellular Intelligence, bringing AI into medicine via a Parkinson’s drug
Fortune